ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 242 filers reported holding ACCELERON PHARMA INC in Q3 2020. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $3,451,000 | +33.7% | 20,052 | -2.5% | 0.02% | +40.0% |
| Q2 2021 | $2,581,000 | -5.1% | 20,565 | +2.6% | 0.02% | -16.7% |
| Q1 2021 | $2,719,000 | +1.4% | 20,049 | -4.3% | 0.02% | +5.9% |
| Q4 2020 | $2,682,000 | -14.2% | 20,960 | -24.5% | 0.02% | -26.1% |
| Q3 2020 | $3,126,000 | -2.4% | 27,775 | -17.4% | 0.02% | -8.0% |
| Q2 2020 | $3,202,000 | +31.8% | 33,611 | -48.3% | 0.02% | +316.7% |
| Q3 2017 | $2,429,000 | +20.2% | 65,051 | -2.1% | 0.01% | +20.0% |
| Q2 2017 | $2,020,000 | +11.9% | 66,474 | -2.5% | 0.01% | 0.0% |
| Q1 2017 | $1,805,000 | +6.5% | 68,182 | +2.7% | 0.01% | 0.0% |
| Q4 2016 | $1,695,000 | +59.9% | 66,406 | +89.5% | 0.01% | +66.7% |
| Q3 2014 | $1,060,000 | -16.9% | 35,038 | -6.7% | 0.00% | 0.0% |
| Q2 2014 | $1,276,000 | – | 37,552 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 42,030 | $3,777,000 | 6.01% |
| Artal Group S.A. | 1,500,000 | $134,805,000 | 5.70% |
| GREAT POINT PARTNERS LLC | 535,627 | $48,137,000 | 5.03% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 211,038 | $18,966,000 | 3.47% |
| Cormorant Asset Management, LP | 825,000 | $74,143,000 | 3.44% |
| Graticule Asia Macro Advisors LLC | 48,700 | $4,377,000 | 3.20% |
| Avoro Capital Advisors LLC | 860,000 | $77,288,000 | 2.61% |
| QVT Financial LP | 120,264 | $10,808,000 | 2.52% |
| Ikarian Capital, LLC | 316,900 | $28,480,000 | 2.14% |
| Avidity Partners Management LP | 166,000 | $14,918,000 | 2.06% |